🇺🇸 FDA
Patent

US 8790639

Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin

granted A61KA61K38/48A61P

Quick answer

US patent 8790639 (Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/48, A61P, A61P31/04